Concord Medical Services (NYSE:CCM) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next?

Concord Medical Services Holdings Limited (NYSE:CCM) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.25 and traded as high as $5.11. Concord Medical Services shares last traded at $5.0790, with a volume of 32,136 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Concord Medical Services Stock Performance

The firm has a fifty day moving average of $4.83 and a 200-day moving average of $4.25. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33.

Concord Medical Services (NYSE:CCM) last posted its quarterly earnings results on Wednesday, April 29th. The company reported ($1.08) earnings per share for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.